Masaki Kato

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease

Motoyuki Kohjima, Munechika Enjoji, Nobito Higuchi et al. · International Journal of Molecular Medicine · 2007 · 525 citations · Full text

Pathology, Fatty Liver Disease, Metabolic Syndrome +18

SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease

Motoyuki Kohjima, Nobito Higuchi, Masaki Kato et al. · International Journal of Molecular Medicine · 2008 · 362 citations · Full text

Fatty Liver Disease, Insulin Signaling, Obesity +21

Liver X receptor in cooperation with SREBP‐1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease

Nobito Higuchi, Masaki Kato, Yuki Shundo et al. · Hepatology Research · 2008 · 280 citations

A Platform of C-type Lectin-like Receptor CLEC-2 for Binding O-Glycosylated Podoplanin and Nonglycosylated Rhodocytin

Masamichi Nagae, Kana Morita‐Matsumoto, Masaki Kato et al. · Structure · 2014 · 113 citations

Signal Transduction, Biochemistry, G Protein-coupled Receptor +10

Short‐term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct‐acting anti‐viral treatment

Eiichi Ogawa, Norihiro Furusyo, Hideyuki Nomura et al. · Alimentary Pharmacology & Therapeutics · 2017 · 111 citations · Full text